Cytokinetics, Incorporated (CYTK) Lawsuit – Investors Urged to Contact Levi & Korsinsky Before November 17, 2025

NEW YORK, NY / ACCESS Newswire / October 21, 2025 / If you suffered a loss on your Cytokinetics, Incorporated (NASDAQ:CYTK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cytokinetics-incorporated-lawsuit-submission-form-2?prid=173334&wire=1&utm_campaign=4 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call […]

Lost Money on Fly-E Group, Inc. (FLYE)? Urged to Join Class Action Before November 10, 2025 – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / October 21, 2025 / If you suffered a loss on your Fly-E Group, Inc. (NASDAQ:FLYE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fly-e-group-inc-lawsuit-submission-form?prid=173333&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

TNDM ACTIVE INVESTIGATION: Lost Money on Tandem Diabetes Care, Inc.? Contact Levi & Korsinsky Now

NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Tandem Diabetes Care, Inc. ("Tandem Diabetes Care, Inc.") (NASDAQ:TNDM) concerning possible violations of federal securities laws. Tandem disclosed on August 7, 2025, that a malfunction had been identified in some of

RCI Hospitality Holdings, Inc. (RICK) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of November 20, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / October 21, 2025 / If you suffered a loss on your RCI Hospitality Holdings, Inc. (NASDAQ:RICK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rci-hospitality-holdings-inc-lawsuit-submission-form?prid=173331&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

Hyspec Homes Expands Custom Home Building Services Across Wollongong and Greater Sydney

Sydney, Oct. 21, 2025 (GLOBE NEWSWIRE) — SUTHERLAND SHIRE, NSW – October 21, 2025 – – Hyspec Homes, a residential building company recognised for its high-specification construction and community-based reputation, has announced the expansion of its custom home building services into Wollongong and additional parts of Greater Sydney. The move marks a significant step in

PADCEV™ (enfortumab vedotin-ejfv) Plus KEYTRUDA® (pembrolizumab) sBLA Granted FDA Priority Review for Treatment of Certain Patients with Muscle-Invasive Bladder Cancer

Results from the pivotal EV-303 trial demonstrated that, when used before and after surgery, the combination reduced the risk of recurrence, progression or death by 60% and the risk of death by 50% in cisplatin-ineligible patients with muscle-invasive bladder cancer If approved, PADCEV plus KEYTRUDA could fundamentally change the treatment approach for patients with this

Hyspec Homes Expands Custom Home Building Services Across Wollongong and Greater Sydney

Hyspec Homes Expands Custom Home Building Services Across Wollongong and Greater Sydney GlobeNewswire October 21, 2025 Sydney, Oct. 21, 2025 (GLOBE NEWSWIRE) — SUTHERLAND SHIRE, NSW – October 21, 2025 – – Hyspec Homes, a residential building company recognised for its high-specification construction and community-based reputation, has announced the expansion of its custom home building

ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CYTK

NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / WHY: New York, N.Y., October 21, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. (NASDAQ:CYTK) between December 27, 2023 and May 6, 2025, both dates inclusive (the "Class Period"), of the important November

NGG Investor News: If You Have Suffered Losses in National Grid plc (NYSE: NGG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

(NYSE:NGG), NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of National Grid plc (NYSE: NGG) resulting from allegations that National Grid plc may have issued materially misleading business information to the investing public. SO WHAT:

Scroll to Top